Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Multiplace Series
Hard-Shell Multiplace·2-18+ person
Pressure3 ATA
$150,000 - $400,000+
●●○○Emerging Evidence
Hyperbaric Therapy for Anti-Aging & Longevity
From telomere lengthening to Bryan Johnson's biomarker protocol — the emerging science of pressurized oxygen for aging.
Key Takeaways
- The 2020 Tel Aviv University study showed HBOT at 2.0 ATA increased telomere length by 20–38% in adults 64+.
- Senescent T-cells (a driver of aging) decreased by 10–37% after 60 HBOT sessions in the same study.
- Bryan Johnson's 60-session protocol produced: telomere length +2.6%, VEGF +300%, pTau -28.6%.
- The mechanism is the "hyperoxic-hypoxic paradox" — high oxygen triggers regenerative hypoxia pathways.
- No published evidence supports anti-aging benefits at 1.3 ATA — the studied protocol uses 2.0 ATA.
- HBOT for anti-aging is not FDA-approved and is not covered by insurance.
What is Anti-Aging & Longevity?
Longevity and anti-aging have become one of the fastest-growing use cases for hyperbaric oxygen therapy, driven largely by two forces: the 2020 Tel Aviv University study that showed HBOT could lengthen telomeres and reduce senescent cells, and Bryan Johnson's highly publicized 60-session protocol. The biohacking community has embraced HBOT as a tool for slowing biological aging — and the early research, while still in its infancy, is genuinely compelling. This is not an FDA-approved indication, and the long-term effects of repeated HBOT for longevity are not yet established.
How Hyperbaric Therapy Helps Anti-Aging & Longevity
The anti-aging mechanism centers on a phenomenon called the "hyperoxic-hypoxic paradox." During HBOT, tissues are exposed to abnormally high oxygen levels. When the session ends and oxygen returns to normal, the body interprets this relative drop as hypoxia — triggering hypoxia-inducible factor (HIF) pathways that normally activate at altitude. This paradox stimulates: telomere lengthening (the protective caps on chromosomes that shorten with age), reduction of senescent cells ("zombie cells" that drive inflammation and aging), increased VEGF production (new blood vessel formation), enhanced stem cell mobilization, and reduced systemic inflammation. The effect is essentially triggering the body's regenerative responses without actual tissue damage.
Recommended Protocol
Pressure
2.0 ATA
Sessions
60 sessions
Duration
60–90 minutes per session
What Does the Evidence Say?
●●○○Emerging Evidence
The landmark 2020 Tel Aviv University study (Hachmo et al.) randomized 35 healthy adults aged 64+ to 60 sessions of HBOT at 2.0 ATA. Results: telomere length increased by 20–38% (equivalent to reversing 10+ years of aging) and senescent CD4/CD8 T-cells decreased by 10–37%. Bryan Johnson's personal protocol at 2.0 ATA for 60 sessions showed: telomere length +2.6%, pTau (neurodegeneration marker) -28.6%, VEGF +300%, systemic inflammation below detectable levels. These results are striking but must be contextualized: the Tel Aviv study was small, the follow-up period was limited, and it is not yet known whether these biomarker improvements translate to actual lifespan extension.
Off-Label Use
Anti-Aging & Longevity is not an FDA-approved indication for HBOT. Treatment is considered off-label and is typically not covered by insurance. Consult your physician before starting any HBOT protocol.
Recommended Chambers for Anti-Aging & Longevity
Based on the protocol requirements — minimum 2 ATA, Clinical Grade or Advanced Wellness tier. Sorted by clinical credibility score.
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 34
Hard-Shell Monoplace·1-person
Pressure3 ATA
$50,000 - $90,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 36
Hard-Shell Monoplace·1-person
Pressure3 ATA
$55,000 - $95,000
Clinical GradeFDA Cleared
For Maximum Comfort
Perry Baromedical
Sigma 40
Hard-Shell Monoplace·1-person
Pressure3 ATA
$65,000 - $110,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 40-II
Hard-Shell Multiplace·2-person
Pressure3 ATA
$100,000 - $160,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma Elite
Hard-Shell Monoplace·1-person
Pressure3 ATA
$80,000 - $130,000
Frequently Asked Questions
Can HBOT actually reverse aging?
The Tel Aviv University study showed HBOT can lengthen telomeres and reduce senescent cells — both biomarkers of biological aging. Whether this translates to actual lifespan extension or healthspan improvement is not yet established. The biomarker changes are real and measurable, but calling it "aging reversal" is premature. Think of it as one of the most promising leads in longevity research, not a proven solution.
What is Bryan Johnson's HBOT protocol?
Bryan Johnson used 60 sessions of HBOT at 2.0 ATA, 60 minutes each, as part of his Blueprint longevity program. His published results: telomere length +2.6%, pTau -28.6%, VEGF +300%, systemic inflammation eliminated. He used a clinical-grade hard-shell chamber — not a home soft-shell unit.
Will a 1.3 ATA chamber work for anti-aging?
The telomere study used 2.0 ATA exclusively. There is no published evidence showing telomere lengthening or senescent cell reduction at 1.3 ATA. The hyperoxic-hypoxic paradox that drives the anti-aging mechanism requires significant oxygen fluctuation — which is proportional to pressure. For longevity protocols based on current research, 2.0 ATA is the studied standard.
How much does a longevity HBOT protocol cost?
At clinic rates of $150–$300 per session, a 60-session protocol costs $9,000–$18,000. A clinical-grade home chamber ($50,000–$150,000) makes economic sense for ongoing use but is a major investment. Some advanced-wellness hard-shell chambers in the $20,000–$60,000 range can reach 2.0 ATA and may be sufficient for home longevity protocols.
Related Conditions
Sources & References
Last updated: March 2026. Data sourced from manufacturer specifications, FDA databases, and published clinical research.
Ready to compare chambers?
Use our filterable directory to find chambers that match your protocol requirements.